Tag: Endologix

Torus stent graft (PQ Bypass)

Endologix announces completion of enrolment in TORUS 2 study for PAD...

Endologix has completed enrolment in the TORUS 2 investigational device exemption (IDE) clinical study in the USA, a press release reports. The TORUS 2...

VEITH 2021: Two-year follow-up data from EVAS2 IDE study delivered

The confirmatory EVAS2 clinical study to evaluate the safety and effectiveness of Endologix's Nellix endovascular aneurysm sealing system (EVAS) for the treatment of infrarenal...

Endologix names Matthew Thompson president and CEO

Endologix has announced the appointment of Matthew Thompson as president and chief executive officer. Thompson will also join Endologix’s board of directors. Richard Mott,...

Endologix receives FDA Breakthrough Device designation for ChEVAS system

Endologix today announced the company’s ChEVAS (chimney endovascular aneurysm sealing) system has been granted a Breakthrough Device designation from the US Food and Drug...

Endologix announces acquisition of PQ Bypass

Endologix recently announced it has completed the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses an unmet need...

Endologix receives CE mark for Alto abdominal stent graft system

Endologix recently announced that it has received a CE mark for the Alto abdominal stent graft system. “We are very excited to receive a CE...
Nellix aneurysm sealing system

Endologix announces reinstatement of CE mark for its Nellix endovascular aneurysm...

Endologix recently announced that the EC Certificate of Conformity (CE mark) for the Nellix endovascular aneurysm sealing system (Nellix system) has been reinstated by...
CE

Nellix system CE Mark suspended

The CE Mark for the Nellix endovascular aneurysm sealing system (Endologix) has been suspended by its Notified Body, GMED, following a voluntary recall and...
CE

Unrestricted sales of the Nellix System to cease as use is...

Unrestricted sales and use of the Nellix System (Endologix) will cease immediately, in order to ensure optimal outcomes for patients, according to Endologix. The...

First patients treated with Endologix’s Ovation Alto abdominal stent graft system

The first use of Endologix’s Ovation Alto abdominal stent graft system has been reported in two patients with abdominal aortic aneurysms (AAA). The patients...